Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc.

NNASDAQ:XLO
8.71
USD
+0.03
(+0.35%)
-1.81EPS
63.04MMarket Cap
Nov 05Next Earn

Xilio Therapeutics, Inc. Documents

Q3 FY2024 · Quarterly report

November 7, 2024 · 172 pages

Read Xilio Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q3 FY2024 documents